DoW Autism Clinical Trial Award
Open. Closes October 22, 2026, 0 days from October 22, 2026, as posted on Grants.gov. Posted by Defense Health Agency Contracting Activity - DHACA, opportunity number HT942526ARPCTA.
Get a first draft in your own AI assistant
Free, no account. Add CedarGrant to Claude, then paste this into a new chat. Your assistant reads the official notice, asks you a few questions and writes a first draft in the notice's format.
Use CedarGrant to help me apply for DoW Autism Clinical Trial Award (HT942526ARPCTA): https://simpler.grants.gov/opportunity/362530
Already writing? Paste this instead, with your draft attached:
Use CedarGrant to make a Requirements Map and run a Reviewer Panel on my draft for HT942526ARPCTA.
Notice facts
| Agency | Defense Health Agency Contracting Activity - DHACA |
|---|---|
| Opportunity number | HT942526ARPCTA |
| Assistance listing | 12.420 |
| Funding instrument | Grant |
| Category | Science and Technology and other Research and Development |
| Posted | May 21, 2026 |
| Closes | October 22, 2026 |
| Award range | Not stated |
| Expected number of awards | 1 |
| Total program funding | $3,250,000 |
| Cost sharing or matching | Not required, per the notice |
| Applicant types listed | Unrestricted (any type of organization, subject to the notice's eligibility text) |
| Additional eligibility information | None listed |
| Where to apply | Check the notice for where and how to submit. |
As posted on Grants.gov, checked October 21, 2026. CedarGrant lists what the notice states; it does not judge whether an organization is eligible. The official notice and its modifications control.
Summary from the notice
Summary: The fiscal year 2026 (FY26) Autism Research Program (ARP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of autism. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials…
Official notice and documents
- FY26 ARP Academic Statement.pdf (Full Announcement)
- FY26 ARP CTA ECI Eligibility Statement.pdf (Full Announcement)
- HT942526ARPCTA_GG.pdf (Full Announcement)
Similar open grants
| Closes | Grant | Agency | Award range |
|---|---|---|---|
| October 22, 2026 0 days left | DoW Arthritis Clinical Research Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Arthritis Translational Research Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Autism Career Development Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Autism Idea Development Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Tick-Borne Disease Idea Development Award | Defense Health Agency Contracting Activity - DHACA | Not stated |